about
Increased expression of PITX2 transcription factor contributes to ovarian cancer progressionCell-cell and cell-matrix dynamics in intraperitoneal cancer metastasisEpithelial ovarian cancer and recreational physical activity: A review of the epidemiological literature and implications for exercise prescriptionMutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.Identification of quiescent, stem-like cells in the distal female reproductive tractMammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTENControlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysisTargeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cellsAberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancerCarboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot StudyFOXO1/3 and PTEN Depletion in Granulosa Cells Promotes Ovarian Granulosa Cell Tumor Development.Potential role of coregistered photoacoustic and ultrasound imaging in ovarian cancer detection and characterization.Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearanceLow-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model.Changes in gene expression and cellular architecture in an ovarian cancer progression model.CXCL12 expression by healthy and malignant ovarian epithelial cells.The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesisElafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors.Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer.Expression and function of androgen receptor coactivator p44/Mep50/WDR77 in ovarian cancerGenome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome.Reproductive and hormonal factors in association with ovarian cancer in the Netherlands cohort study.Assessment of ovarian cancer spheroid attachment and invasion of mesothelial cells in real time.The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cellsInherited variants in regulatory T cell genes and outcome of ovarian cancer.Stem cell-like gene expression in ovarian cancer predicts type II subtype and prognosisModeling high-grade serous ovarian carcinogenesis from the fallopian tubeCirculating inflammation markers and risk of epithelial ovarian cancerIdentification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancerMolecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.Immunohistological insight into the correlation between neuropilin-1 and epithelial-mesenchymal transition markers in epithelial ovarian cancer.Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas.Ex vivo culture of primary human fallopian tube epithelial cells.The new face of ovarian cancer modeling: better prospects for detection and treatment.Three-dimensional modeling of ovarian cancer.Induction of ovarian cancer and DNA adducts by Dibenzo[a,l]pyrene in the mouse.A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.VAV3 Overexpressed in Cancer Stem Cells Is a Poor Prognostic Indicator in Ovarian Cancer PatientsWild-type tumor repressor protein 53 (Trp53) promotes ovarian cancer cell survival.Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.
P2860
Q21090912-16784B91-C51F-4195-A8E1-3EE2696CD1C6Q26851836-9A313792-C8BF-4F88-B5E0-04B9C5294039Q26858927-C5F2F378-8D91-4727-9ACE-D044899C0BE9Q27333756-324988A7-6A92-4D48-9069-6284743B782AQ27334330-384030F6-3F33-43E2-ACAB-21873AC80D1DQ27335766-653CB9BB-8C8A-4F7C-9A16-DF340F8224B6Q28281796-7BCCAE40-7BA0-4E5A-8050-6713745303D1Q28484496-23DA9133-BA6A-47C4-A054-98FB5E2B8F54Q28543351-289B24F6-1A3D-4C3D-946F-BDABB0C025EBQ28550381-424CD5F7-358A-410F-AA21-D3D41056DCBDQ30358011-9C1DEA4D-C8E2-492D-98F2-C820EF6E4DF2Q30477398-A27D8EF2-01D0-4737-8D80-12132E11D30DQ30579225-2766284D-A43B-455D-836C-355B52B80396Q33773081-7F74380A-E197-481F-A952-EE0C794DCCC5Q33842047-B938C1E2-CAE9-4A61-B2FF-8528180DAA8DQ33848551-CA26B9C1-0B60-4605-8E21-1CE2CF93A90EQ33926671-FA2423CB-1F64-484D-A7E4-C09E3E70497CQ33955266-FAC794C2-D126-4963-A543-B548B97B794EQ33959320-AF744B9D-020A-464D-82F9-A6A0A90423AAQ34056207-49B7E814-72DF-403B-8F2B-7143379C755BQ34166257-48FC406A-9E5A-41EF-9EE6-6EE4CE106605Q34268606-8E5DE319-5CF9-4F57-A64F-38E8C86887ADQ34350732-54A8416C-4B99-435C-8C15-291E68B51164Q34552289-A762B61F-B2BF-4E5B-A953-EF4B9341DD62Q34575290-20B11C82-7459-4B77-8509-20F70EE3E6CEQ34639023-35470A8A-8DE5-4D6F-8FA1-D9D6BD95B5A5Q34938333-18C5B0C1-20F6-40EB-A07E-C2FB3D03D069Q34949061-DC53C1FA-0781-4D35-A877-C7ED877CE610Q35044404-1AFBCB33-B464-4952-9366-C037FE54B7DDQ35116008-8057E93E-B9B7-47B0-9058-8843CDCE099CQ35172301-C75E9152-9FA0-4002-95FF-A08DB25AC6F2Q35209384-54D73318-D615-421C-8A4A-7FE322E24ED5Q35392397-16DFD865-967B-4801-9CB6-A4E01A9531E0Q35507860-6AC8BCBB-20C8-4E59-B6BE-AC44C389D75FQ35591610-F1FAF104-3554-445E-9BA4-88BE41FE8B4DQ35783882-692DFBA2-F4DD-4BE1-97AD-CC8C3EE1D989Q35832201-E8F98874-2807-452A-A61C-CC2645443A60Q35844366-4C8A0325-34CB-4CC0-A500-B01AE472A417Q35872729-38768274-6F71-4BFC-B5AA-88E7C59FD702Q35897417-26294993-2364-413A-899D-6E5222D8BDD6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ovarian cancer pathogenesis: a model in evolution.
@en
Ovarian cancer pathogenesis: a model in evolution.
@nl
type
label
Ovarian cancer pathogenesis: a model in evolution.
@en
Ovarian cancer pathogenesis: a model in evolution.
@nl
prefLabel
Ovarian cancer pathogenesis: a model in evolution.
@en
Ovarian cancer pathogenesis: a model in evolution.
@nl
P2860
P356
P1433
P1476
Ovarian cancer pathogenesis: a model in evolution.
@en
P2093
Alison M Karst
Ronny Drapkin
P2860
P304
P356
10.1155/2010/932371
P577
2009-09-06T00:00:00Z